Nathalie Adda - Net Worth and Insider Trading

Nathalie Adda Net Worth

The estimated net worth of Nathalie Adda is at least $432,727 dollars as of 2024-04-26. Nathalie Adda is the Sr. VP & Chief Medical Officer of Enanta Pharmaceuticals Inc and owns about 34,982 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $432,727. Details can be seen in Nathalie Adda's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nathalie Adda has not made any transactions after 2022-04-04 and currently still holds the listed stock(s).

Transaction Summary of Nathalie Adda

To

Nathalie Adda Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nathalie Adda owns 1 companies in total, including Enanta Pharmaceuticals Inc (ENTA) .

Click here to see the complete history of Nathalie Adda’s form 4 insider trades.

Insider Ownership Summary of Nathalie Adda

Ticker Comapny Transaction Date Type of Owner
ENTA Enanta Pharmaceuticals Inc 2022-04-04 Sr. VP & Chief Medical Officer

Nathalie Adda Latest Holdings Summary

Nathalie Adda currently owns a total of 1 stock. Nathalie Adda owns 34,982 shares of Enanta Pharmaceuticals Inc (ENTA) as of April 4, 2022, with a value of $432,727.

Latest Holdings of Nathalie Adda

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ENTA Enanta Pharmaceuticals Inc 2022-04-04 34,982 12.37 432,727

Holding Weightings of Nathalie Adda


Nathalie Adda Form 4 Trading Tracker

According to the SEC Form 4 filings, Nathalie Adda has made a total of 6 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 83,344 shares on April 4, 2022, which brought Nathalie Adda around $6 Million.

Insider Trading History of Nathalie Adda

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nathalie Adda Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nathalie Adda Ownership Network

Ownership Network List of Nathalie Adda

No Data

Ownership Network Relation of Nathalie Adda


Nathalie Adda Owned Company Details

What does Enanta Pharmaceuticals Inc do?

Who are the key executives at Enanta Pharmaceuticals Inc?

Nathalie Adda is the Sr. VP & Chief Medical Officer of Enanta Pharmaceuticals Inc. Other key executives at Enanta Pharmaceuticals Inc include Chief Medical Officer Scott T. Rottinghaus , Sr. VP & Business Dev. Brendan Luu , and Sr. VP & New Product Dev. Tara Lynn Kieffer .

Enanta Pharmaceuticals Inc (ENTA) Insider Trades Summary

Over the past 18 months, Nathalie Adda made no insider transaction in Enanta Pharmaceuticals Inc (ENTA). Other recent insider transactions involving Enanta Pharmaceuticals Inc (ENTA) include a net sale of 65,142 shares made by Jay R. Luly , a net sale of 16,337 shares made by Yat Sun Or , and a net sale of 12,852 shares made by Paul J Mellett .

In summary, during the past 3 months, insiders sold 0 shares of Enanta Pharmaceuticals Inc (ENTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,822 shares of Enanta Pharmaceuticals Inc (ENTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,822 shares.

Enanta Pharmaceuticals Inc (ENTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Enanta Pharmaceuticals Inc Insider Transactions

No Available Data

Nathalie Adda Mailing Address

Above is the net worth, insider trading, and ownership report for Nathalie Adda. You might contact Nathalie Adda via mailing address: C/o Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown Ma 02472.

Discussions on Nathalie Adda

No discussions yet.